ReviewCancer drug resistance (Alhambra, Calif.)2019

Tailored therapy in patients treated with fluoropyrimidines: focus on the role of dihydropyrimidine dehydrogenase.

Filippo Merloni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.